Trusted Resources: Education
Scientific literature and patient education texts
Psychopathological Dimensions in Subjects With Hereditary ATTR V30M Amyloidosis and Their Relation With Life Events Due to the Disease
source: Amyloid: The International Journal of Experimental and Clinical Investigation
year: 2018
authors: Lopes A, Fonseca I, Sousa A, Rodrigues C, Branco M, Coelho T, Sequeiros J, Freitas P
summary/abstract:Background:
Chronic physical illness has been associated with emotional distress. Chronic diseases may change usual family patterns with economic, social and family losses. Hereditary ATTR V30M amyloidosis is a rare, fatal inherited systemic amyloidosis, with chronic evolution and beginning in adulthood.
Aims and Methods:
To evaluate psychopathological dimensions and how they correlated with disease-related life events, 209 symptomatic and asymptomatic carriers, participated in the study. Sociodemographic and Family and Personal History Disease questionnaires and brief symptom inventory (BSI) were applied.
Results:
BSI indices, global severity index (GSI), positive symptom index (PSI) and positive symptom total (PST) scored higher than general population. Independent predictors for GSI >0.83 were female sex (OR = 3.46, p = .005) and being symptomatic carriers (OR = 3.03, p = .039). Independent predictors of a PST >26.99 were female sex (OR = 3.74, p = .012) symptomatic carrier (OR = 5.32, p = .025), age between 15 and 24 years at affected parent’s death (OR = 5.26, p = .04). Independent predictors of a PSI >1.56 were being asymptomatic carrier (OR = 6.3, p = .036); to have children (OR = 3.19, p = .043) and have ≤14 years at parent’s disease onset (OR = 6.39, p = .05).
Conclusions:
Results point to an important vulnerability of this population for psychological distress and psychiatric disease. Early life events related to disease, being sick and sex are associated with psychopathological distress.
organization: Centro Hospitalar do Porto, Portugal; Universidade do Porto, Portugal; Instituto de Saúde Pública da Universidade do Porto (ISPUP), PortugalDOI: 10.1080/13506129.2018.1428795
read more full text
Related Content
-
Liana (Brazil) – Living With hATTR Amyloidosishttps://www.youtube.com/watch?v=t-tyIYoK...
-
Tips for Living Your Best Life With hATTR AmyloidosisAfter being diagnosed with hATTR amyloid...
-
ISA 2020 | Genetic Signatures & Hereditary ATTR Amyloidosishttps://www.youtube.com/watch?v=ToTGG-zb...
-
FDA Approves Patisiran Infusion for Hereditary Transthyretin-Mediated AmyloidosisThe FDA announced that it has approved p...
-
ATTR Treatment: Navigating Through the Complexity of the Healthcare System – ASG Webinar 5/7https://www.youtube.com/watch?v=IzC_yaqs...
-
Diagnosis, Prognosis, and Therapy of Transthyretin AmyloidosisTransthyretin amyloidosis is a fatal dis...
-
Liana (Brasil) – Convivendo com Amiloidose hATTRhttps://www.youtube.com/watch?v=S5N3Wj8_...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.